NovoBliss

Gandhinagar, India Founded: 2021 • Age: 5 yrs
Offers clinical trials, regulatory consultancy, and medical services for health innovations.

About NovoBliss

NovoBliss is a Healthcare company based in Gandhinagar (India) founded in 2021 by Nayan Patel and Maheshvari Patel. It offers clinical trials, regulatory consultancy, and medical services for health innovations. It operates on a B2B model in Healthcare and Consumer sectors. The company has 18 employees. Its chief executive, as recorded, is Nayan Patel. Its website novobliss.in draws about 681 thousand monthly visits. Its Indian entity Novobliss Research Private Limited reported revenue of β‚Ή4.65 Cr. NovoBliss offers products and services including Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review. Its focus areas include Health and Life Sciences, Clinical Research, Therapeutics and Cosmetic Trials.

Company details

NovoBliss is a company based in Ahmedabad, India, that specializes in clinical research services, regulatory consultancy, and medical writing. They conduct trials for cosmetics, nutraceuticals, and therapeutic products, ensuring compliance and quality. Working with global clients, they advance innovation in health sciences through expert teams and partnerships, focusing on areas like biostatistics and laboratory testing.

  • Headquarters Gandhinagar, India
  • Employees 18
  • Founders Nayan Patel, Maheshvari Patel
  • Sectors
    Healthcare
    Consumer
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website novobliss.in
  • Social LinkedIn Facebook Instagram
  • Legal Name Novobliss Research Private Limited
  • Date of Incorporation 05 Oct, 2021
  • Jurisdiction Ahmedabad, Gujarat, India
Key Metrics
  • Annual Revenue
    ₹4.65 Cr

    FY 2024 · +142% YoY

  • Net Profit
    ₹91.3 Lakh

    FY 2024 · 20% margin

  • EBITDA
    ₹1.12 Cr

    FY 2024 · 24% margin

  • Employee Count
    18

Products & Services of NovoBliss

NovoBliss offers a comprehensive portfolio of products and services, including Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review.

Regulatory Consultancy
Consulting Services

Provides advice on regulatory compliance for health products

Clinical Services
Research Services

Conducts trials for cosmetics and nutraceuticals

Biostatistics and Programming
Data Services

Offers statistical analysis for clinical studies

Medical Writing
Documentation Services

Prepares reports and documents for health research

Medical Review
Review Services

Performs evaluations for clinical and therapeutic studies

Board of directors of Novobliss Research Private Limited (NovoBliss)

Novobliss Research Private Limited is the primary company behind NovoBliss. The board of Novobliss Research Private Limited currently have 2 directors; the longest-serving is Maheshvari Nayan Patel, appointed in 2021.

DirectorDesignationAppointedTenureEntity
Maheshvari Nayan Patel
DIN 09346831
Director05 Oct 20215 yrs 1 moNovobliss Research Private Limited
Nayan Kaushikbhai Patel
DIN 09346832
Director05 Oct 20215 yrs 1 moNovobliss Research Private Limited

People of NovoBliss

2 people are tracked at NovoBliss (2 in leadership); the tracked headcount is 18.

NameRoleGroup
Co-Founder, CEOLeadership
Co-FounderLeadership
Premium access

Complete people profiles for NovoBliss

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of NovoBliss

Figures of Novobliss Research Private Limited, the primary company behind NovoBliss, for FY 2024. Revenue was ₹4.65 Cr (+142% year on year). Net profit was ₹91.3 Lakh (20% margin). EBITDA was ₹1.12 Cr (24% margin).

  • ₹4.65 CrRevenue · FY 2024 · +142% YoY
  • ₹91.3 LakhNet profit · 20% margin
  • ₹1.12 CrEBITDA · 24% margin
  • ₹1 LakhPaid-up capital
  • 18Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Novobliss Research Private Limited are on its company page.

Premium access

Detailed financial statements for NovoBliss

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of NovoBliss

The website of NovoBliss (novobliss.in) receives about 680.7K visits a month.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with NovoBliss. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for NovoBliss

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Clinical Trials & Research Tech

2 companies that operate in the same segment as NovoBliss (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
2004Ahmedabad, Gujarat, IndiaUSD 74.68 M1,618
Generic injectables for oncology and anesthesiology are manufactured.
1989Hyderabad, Telangana, IndiaUSD 4.22 M228
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about NovoBliss

NovoBliss was founded in 2021.

NovoBliss is headquartered in Gandhinagar, India. It is registered at Gandhinagar, Gujarat, India.

Nayan Patel is the CEO of NovoBliss, as recorded in our data. They have also founded this company.

NovoBliss has 18 employees.

The primary company behind NovoBliss, Novobliss Research Private Limited, reported revenue of β‚Ή4.65 Cr for FY 2024, up 142% year on year.

NovoBliss is a company based in Ahmedabad, India, that specializes in clinical research services, regulatory consultancy, and medical writing. They conduct trials for cosmetics, nutraceuticals, and therapeutic products, ensuring compliance and quality. Working with global clients, they advance innovation in health sciences through expert teams and partnerships, focusing on areas like biostatistics and laboratory testing.

NovoBliss offers Regulatory Consultancy, Clinical Services, Biostatistics and Programming, Medical Writing, and Medical Review.

NovoBliss operates through Novobliss Research Private Limited.

The legal entities of NovoBliss currently have 2 directors, including Maheshvari Nayan Patel, Nayan Kaushikbhai Patel.

The website of NovoBliss receives about 681 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available